Metformin/cp-690,550 (DrugBank: Metformin)
21 diseasesID | Disease name (Link within this page) | Number of trials |
---|---|---|
2 | Amyotrophic lateral sclerosis | 0 |
6 | Parkinson disease | 0 |
13 | Multiple sclerosis/Neuromyelitis optica | 0 |
46 | Malignant rheumatoid arthritis | 1 |
49 | Systemic lupus erythematosus | 0 |
60 | Aplastic anemia | 0 |
67 | Polycystic kidney disease | 0 |
75 | Cushing disease | 0 |
77 | Growth hormone secreting pituitary adenoma | 0 |
81 | Congenital adrenal hyperplasia | 0 |
86 | Pulmonary arterial hypertension | 0 |
113 | Muscular dystrophy | 0 |
127 | Frontotemporal lobar degeneration | 0 |
158 | Tuberous sclerosis | 0 |
206 | Fragile X syndrome | 0 |
225 | Congenital nephrogenic diabetes insipidus | 0 |
233 | Wolfram syndrome | 0 |
265 | Lipodystrophy | 0 |
285 | Fanconi anemia | 0 |
299 | Cystic fibrosis | 0 |
301 | Macular dystrophy | 0 |
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NCT01405118 (ClinicalTrials.gov) | June 2011 | 7/7/2011 | Effect Of CP-690,550 On The Pharmacokinetics Of Metformin In Healthy Volunteers | A Phase 1, Open Labeled, Fixed Sequence Study To Estimate The Effect Of CP-690,550 On The Pharmacokinetics Of Metformin In Healthy Volunteers | Rheumatoid Arthritis | Drug: Metformin/CP-690,550 | Pfizer | NULL | Completed | 18 Years | 55 Years | Both | 24 | Phase 1 | Belgium |